Last reviewed · How we verify
DIPHENIDOL HYDROCHLORIDE — Competitive Intelligence Brief
marketed
Anticholinergic
5-hydroxytryptamine receptor 2A, Cytochrome P450 2D6, D(2) dopamine receptor
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
DIPHENIDOL HYDROCHLORIDE (DIPHENIDOL HYDROCHLORIDE).
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| DIPHENIDOL HYDROCHLORIDE TARGET | DIPHENIDOL HYDROCHLORIDE | marketed | Anticholinergic | 5-hydroxytryptamine receptor 2A, Cytochrome P450 2D6, D(2) dopamine receptor | 1967-01-01 | |
| Yupelri | REVEFENACIN | Mylan Ireland Ltd | marketed | Anticholinergic [EPC] | Muscarinic acetylcholine receptor M3 | 2018-01-01 |
| Incruse Ellipta | UMECLIDINIUM | Glaxo Grp England | marketed | Anticholinergic | Muscarinic acetylcholine receptor M4 | 2013-01-01 |
| Tudorza Pressair | ACLIDINIUM BROMIDE | Covis | marketed | Anticholinergic | M3 receptors, beta 2 -adrenergic receptors | 2012-01-01 |
| Spiriva | TIOTROPIUM BROMIDE | Boehringer Ingelheim | marketed | Anticholinergic | Muscarinic acetylcholine receptor M3 | 2004-01-01 |
| Atrovent | IPRATROPIUM | marketed | Anticholinergic | Muscarinic acetylcholine receptor M1 | 1986-01-01 | |
| Librax | CLIDINIUM | Roche | marketed | Anticholinergic | Muscarinic acetylcholine receptor M3 | 1982-01-01 |
Recent regulatory actions (last 90 days)
- — Atrovent · FDA · approved · US
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Anticholinergic class)
- · 4 drugs in this class
- Pearl Therapeutics, Inc. · 3 drugs in this class
- Shionogi · 2 drugs in this class
- Ain Shams University · 1 drug in this class
- Astellas Pharma Inc · 1 drug in this class
- Boehringer Ingelheim · 1 drug in this class
- Covis · 1 drug in this class
- Forest Labs Inc · 1 drug in this class
- Fougera Pharms · 1 drug in this class
- Glaxo Grp England · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- DIPHENIDOL HYDROCHLORIDE CI watch — RSS
- DIPHENIDOL HYDROCHLORIDE CI watch — Atom
- DIPHENIDOL HYDROCHLORIDE CI watch — JSON
- DIPHENIDOL HYDROCHLORIDE alone — RSS
- Whole Anticholinergic class — RSS
Cite this brief
Drug Landscape (2026). DIPHENIDOL HYDROCHLORIDE — Competitive Intelligence Brief. https://druglandscape.com/ci/diphenidol-hydrochloride. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab